| View |
BR-1474_PI_01.pdf
|
BR-1474
|
Semaglutide
|
Wegovy
|
1.7 mg/0.75 mL (2.27 mg/mL)
|
Solution for Injection (SC)
|
Prescription Drug (Rx)
|
Single dose. 1 mL (Net content: 0.75 mL) Type I glass pre-filled syringe with grey chlorobutyl rubber plunger, four (4) 29G stainless steel needles and polyisoprene rubber Type II rigid needle shield assembled in a pen- injector (Box of 1's).
|
Glucagon-like peptide (GLP-1) Analogues
|
Novo Nordisk A/S
|
Denmark
|
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Monitored Release (MR)
|
22 May 2024
|
22 May 2029
|
| View |
BR-1475_PI_01.pdf
|
BR-1475
|
Semaglutide
|
Wegovy
|
1 mg/0.5 mL (2 mg/mL)
|
Solution for Injection (SC)
|
Prescription Drug (Rx)
|
Single dose. 1 mL (Net content: 0.5 mL) Type I glass conten pre-filled syringe with grey chlorobutyl rubber plunger, four (4) 29G stainless steel needles and polyisoprene rubber Type II rigid needle shield assembled in a pen- injector (Box of 1's).
|
Glucagon-like peptide (GLP-1) Analogues
|
Catalent Belgium
|
Belgium
|
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Monitored Release (MR)
|
22 May 2024
|
22 May 2029
|
| View |
BR-1476_PI_01.pdf
|
BR-1476
|
Semaglutide
|
Wegovy
|
0.5 mg/0.5 mL (1 mg/mL)
|
Solution for Injection (SC)
|
Prescription Drug (Rx)
|
Single dose. 1 mL (Net content: 0.5 mL) Type I glass pre-filled syringe with grey chlorobutyl rubber plunger, four (4) 29G stainless steel needles and polyisoprene rubber Type II rigid needle shield assembled in a pen- injector (Box of 1's).
|
Glucagon-like peptide (GLP-1) Analogues
|
Catalent Belgium
|
Belgium
|
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Monitored Release (MR)
|
22 May 2024
|
22 May 2029
|
| View |
BR-1477_PI_01.pdf
|
BR-1477
|
Semaglutide
|
Wegovy
|
0.25 mg/0.5 mL (0.5 mg/mL)
|
Solution for
Injection (SC)
|
Prescription Drug (Rx)
|
Single dose. 1 mL (Net content: 0.5 mL) Type I glass pre-filled syringe with grey chlorobutyl rubber plunger, four (4) 29G stainless steel needles and polyisoprene rubber Type II rigid needle shield assembled in a pen- injector (Box of 1's).
|
Glucagon-like peptide (GLP-1) Analogues
|
Catalent Belgium
|
Belgium
|
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Monitored Release (MR)
|
22 May 2024
|
22 May 2029
|
| View |
|
BR-1478
|
Rituximab
|
Rituxell
|
10 mg/mL
|
Concentrate for Solution for Infusion (IV)
|
Prescription Drug (RX)
|
Type I glass vial with bromobutyl rubber stopper and aluminum crimp cap with polypropylene flip-off cap x 10 mL (Box of 2's); Type I glass vial with bromobutyl rubber stopper and aluminum crimp cap with polypropylene flip-off cap x 50 mL (Box of 1's).
|
Monoclonal Antibodies
|
Joint Stock Company Biocad
|
Russia
|
|
Qualimed Pharma Inc.
|
|
Initial
|
28 February 2024
|
28 February 2029
|
| View |
|
BR-1479
|
Bevacizumab
|
Bevalast
|
25 mg/mL
|
Concentrate for Solution for Infusion (IV)
|
Prescription Drug (RX)
|
Type I glass vial with bromobutyl rubber stopper and aluminum cap with plastic flip off x 4 mL & 6 mL (Box of 1's).
|
Monoclonal Antibodies
|
Joint Stock Company Biocad
|
Russia
|
|
Qualimed Pharma Inc.
|
|
Initial
|
28 February 2024
|
28 February 2029
|
| View |
|
BR-1480
|
Spesolimab
|
Spevigo
|
450 mg/7.5 mL (60 mg/mL)
|
Concentrate for Solution for
Infusion (IV)
|
Prescription (Rx) Drug
|
7.5 mL-net content in 10 mL-capacity Type I glass vial with grey coated serum butyl rubber stopper, and aluminum crimp cap with dark blue plastic button (Box of 2's).
|
Interleukin inhibitors
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
|
Boehringer Ingelheim (Philippines), Inc.
|
Boehringer Ingelheim (Philippines), Inc.
|
Monitored Release (MR)
|
05 April 2024
|
05 April 2029
|
| View |
|
BR-1481
|
Heparin Sodium
|
Hepadur
|
1000 IU/mL
|
Solution for Injection (IV)
|
Prescription Drug (Rx)
|
Transparent USP Type I Vial X 5 mL / (Box of 10's)
|
Antithrombotic agents
|
Tianjin Biochemical Pharmaceutical Co., Ltd
|
China
|
|
Endure Medical Inc
|
Endure Medical Inc.
|
Renewal
|
05 May 2024
|
19 May 2029
|
| View |
|
BR-1482
|
Heparin Sodium
|
Hepadur
|
5000 IU/mL
|
Solution for Injection (IV)
|
Prescription Drug (Rx)
|
Transparent USP Type I vial X 5 mL / (Box of 10's)
|
Antithrombotic agents
|
Tianjin Biochemical Pharmaceutical Co., Ltd
|
China
|
|
Endure Medical Inc.
|
Endure Medical Inc.
|
Renewal
|
27 May 2024
|
19 May 2029
|
| View |
|
BR-1483
|
Meningococcal group B Vaccine (rDNA, component,
adsorbed)
|
Bexsero
|
Formulation:
One dose (0.5 mL) contains:
Recombinant Neisseria meningitidis group B NHBA fusion protein1.2.3 -50 mcg Recombinant Neisseria meningitidis-group B NadA protein1.2.3- 50 mcg
Recombinant Neisseria meningitidis group B fHbp fusion protein1.2.3 -50 mcg
Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain 25 mcg
NZ98/254 measured as amount of total protein containing the PorA P1.42
produced in E. coli cells by recombinant DNA technology
2Adsorbed on Aluminum hydroxide (0.5 mg Al1)
'NHBA (Neisseria Heparin Binding Antigen), NadA (Neisseria adhesin A). (Hbp
(factor H binding protein)
|
Suspension for Injection (IM)
|
Prescription Drug (Rx)
|
0.5 mL in 1.25 mL Luer Lock hydrolytic Type I pre-filled glass syringe with a bromobutyl plunger stopper and rubber tip cap packed with 23G 1 (25mm) and 25G 5/8 (16mm) needles (Box of 1's)
|
Meningococcal Vaccines
|
GlaxoSmithKline Vaccines S.r.1
|
Italy
|
|
GlaxoSmithKline Philippines, Inc.
|
|
Monitored Release (MR)
|
21 May 2024
|
21 May 2029
|
| View |
|
BR-1484
|
Eptacog alfa (activated)
|
NovoSeven RT
|
1 mg
|
Powder for Solution for Injection (IV)
|
Prescription (Rx) Drug
|
One (1) box contains: 2 mL Type I glass vial with gray. chlorobutyl rubber stopper and aluminum snap-off cap + 3 mL (Net content: 1 mL) Type I borosilicate pre-filled glass syringe with bromobutyl rubber stopper, and bromobutyl rubber tip cap (Histidine as solvent) + Vial adapter.
|
Blood Coagulation Factor
|
Novo Nordisk A/S
|
Denmark
|
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Initial (Reapplication)
|
01 July 2024
|
01 July 2029
|
| View |
|
BR-1485
|
Luspatercept
|
Rojusna
|
75 mg
|
Powder for Solution for Injection (SC)
|
Prescription Drug (Rx)
|
2R Type I borosilicate clear glass TopLyoR vial with FlurotecR coated gray bromobutyl rubber stopper and sealed with aluminum flip-off seal and orange polypropylene button (Box of 1's)
|
Antianemic Preparations
|
Patheon Italia S.p.A.
|
Italy
|
Bristol-Myers Squibb Company
|
DKSH Market Expansion Services Philippines Inc.
|
DKSH Market Expansion Services Philippines Inc.
|
Monitored Release (MR)
|
30 July 2024
|
30 July 2029
|
| View |
|
BR-1486
|
Luspatercept
|
Rojusna
|
25 mg
|
Powder for Solution for Injection (SC)
|
Prescription Drug (Rx)
|
2R Type I borosilicate clear glass TopLyoR vial with Fluorotec® gray bromobutyl rubber stopper and sealed with aluminum flip-off seal and yellow polypropylene button (Box of 1's)
|
Antianemic Preparations
|
Patheon Italia S.p.A.
|
Italy
|
Bristol-Myers Squibb Company
|
DKSH Market Expansion Services Philippines Inc.
|
DKSH Market Expansion Services Philippines Inc.
|
Monitored Release (MR)
|
30 July 2024
|
30 July 2029
|
| View |
|
BR-220
|
Rabbies Vaccine (Inactivated)(Wistar Strain Rabies)
|
Verorab
|
2.5 IU/ 0.5 mL
|
Powder For Suspension(ID/IM)
|
Prescription Drug (RX)
|
Type I glass vial with chlorobutyl stopper and a cap + 0.5 mL Type I pre-filled glass syringe with bromobutyl. plunger stopper 0.4% Sodium chloride (as diluent) (Box of 1's and 10's)
|
-
|
Sanofi Pasteur, Inc.
|
France
|
N/A
|
Sanofi Pasteur, Inc.
|
Zuellig Pharma Corporation
|
Renewal
|
26 May 2023
|
10 December 2027
|
| View |
|
BR-233
|
Hepatitis B (rDNA) Vaccine
|
Engerix-B
|
20mcg/mL
|
Suspension for IM Injection (Thiomersal-free/Preservative-free)
|
Prescription Drug (RX)
|
1 mL Monodose Vial (Box of 1's). Adult dose.
|
Vaccine
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
N/A
|
GlaxoSmithKline Philippines, Inc.
|
N/A
|
Renewal
|
04 June 2021
|
04 December 2024
|
| View |
|
BR-254
|
Hepatitis B (rDNA) Vaccine
|
Engerix-B
|
10mcg/0.5mL
|
Suspension for IM Injection (Thiomersal-free/Preservative-free)
|
Prescription Drug (RX)
|
0.5 mL Monodose Vial (Box of l's, 25's and 100's). Pediatric dose.
|
Vaccine
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
N/A
|
GlaxoSmithKline Philippines, Inc.
|
N/A
|
Renewal
|
04 June 2021
|
04 December 2024
|
| View |
|
BR-280
|
Typhoid Polysaccharide Vaccine
|
Typhim Vi
|
Formulation: Each dose (0.5 mL) contains: Purified Vi capsular polysaccharide of Salmonella typhi (Ty2 strain)...................... 25 mcg
|
Solution for Injection (IM/SC)
|
Prescription Drug (RX)
|
Type I pre-filled glass syringe x 0.5 mL (Box of 1's)
|
-
|
Sanofi Pasteur
|
France
|
N/A
|
Sanofi Pasteur, Inc.
|
Zuellig Pharma Corporation
|
-
|
18 March 2022
|
01 March 2027
|
| View |
|
BR-289
|
Rabbit Anti-Human Thymocyte Immunoglobulin
|
Thymoglobuline
|
5 mg/mL
|
Powder for Solution for Infusion (IV)
|
Prescription Drug (RX)
|
Type I Glass Vial with Chlorobutyl Stopper, Aluminum Seal and Plastic Flip-off Cap (Box of 1's)
|
-
|
Genzyme Polyclonal S.A.S.
|
France
|
N/A
|
Sanofi Aventis Philippines, Inc.
|
N/A
|
Regular Renewal (Compliance)
|
30 March 2022
|
08 February 2026
|
| View |
|
BR-307
|
Hepatitis B Immunoglobulin (Human)
|
Hepabig
|
200 IU/mL
|
Solution For Injection
|
Prescription Drug (RX)
|
1 mL Glass Vial
|
Immunoglobulin
|
Green Cross Corporation
|
Korea
|
|
Vizcarra Pharmaceutical, Inc.
|
Vizcarra Pharmaceutical, Inc.
|
Renewal
|
07 April 2022
|
22 March 2027
|
| View |
|
BR-324
|
Diphtheria-Tetanus Toxoids And Pertussis ( DTP ) Vaccines
|
Perdinus
|
30 IU (25 Lf) / 40 IU (5 Lf) / 4 IU per 0.5 mL
|
Suspension for Injection (IM) (Monodose)
|
Prescription Drug (RX)
|
0.5 mL One Point Cut (OPC) Glass Ampoule (Box of
50's)
|
-
|
Serum Institute of India Private Limited
|
India
|
|
Genpharm, Inc.
|
Genpharm, Inc.
|
-
|
26 February 2021
|
28 December 2025
|